In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Google gave an update on various aspects of its health-related R&D at its annual event The Check Up, including a new collection of artificial intelligence (AI) models intended to support drug ...

Google has added powerful AI tools to Search, including Gemini 2.5 Pro and Deep Search, to give users more detailed answers and research support.

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Britain’s most powerful supercomputer has come online as the Government unveils plans for a major drive in AI research across ...

Traditionally, individuals asked health questions of their primary health care provider. Confidence in that provider as a ...

PATH has launched the largest study of its kind in Africa, recruiting 9,000 participants to test whether AI can help primary ...

Republican Gov. Glenn Youngkin announced on Tuesday that Google will partner with his administration to provide free and ...